Receptor tyrosine kinase inhibitor Sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Sunitinib inhibited endometriotic lesion by promoting peritoneal fluid MDSCs maturation and inhibiting its immunosuppressive functions. It changed the immune microenvironment and inhibited development of endometriosis.
创建时间：
2021-07-10
